The mailing list is the last option I had.
I send attached the jars dependencies in my project and also I paste the
stacktrace if you find more info than me.
oct 16, 2014 12:48:24 PM org.apache.cxf.phase.PhaseInterceptorChain
doDefaultLogging
Advertencia: Interceptor for {
http://clientAPIRest.shared.us2p.uitu.com/}DomainsAPI has thrown exception,
unwinding now
org.apache.cxf.interceptor.Fault: No conduit initiator was found for the
namespace http://cxf.apache.org/transports/http.
at
org.apache.cxf.endpoint.AbstractConduitSelector.getSelectedConduit(AbstractConduitSelector.java:116)
at
org.apache.cxf.endpoint.UpfrontConduitSelector.selectConduit(UpfrontConduitSelector.java:77)
at org.apache.cxf.message.ExchangeImpl.getConduit(ExchangeImpl.java:148)
at
org.apache.cxf.interceptor.MessageSenderInterceptor.getConduit(MessageSenderInterceptor.java:71)
at
org.apache.cxf.interceptor.MessageSenderInterceptor.handleMessage(MessageSenderInterceptor.java:46)
....
What is the best option? What can I do?
Thanks
Regards
*David Roldán*
*UITU: Ubiquitous Internet Technologies Unit *
http://fi2.cat/uitudesc
*i2CAT FOUNDATION*
Gran Capità 2-4 (Nexus I building)
2nd Floor, office 203; 08034 Barcelona
+34 93 553 26 33
2014-10-16 12:39 GMT+02:00 Vassilis Virvilis <[email protected]>:
> Hi David,
>
> You don't have to use Resty-GWT. I misunderstood your setup. I thought you
> were trying to reach CXF from the GWT client side.
>
> Unfortunately I don't know why it doesn't work from GWT server side. It
> should work... Maybe check dependencies - GWT jars bundle some dependencies
> inline...
>
> Vassilis
>
> On 10/16/2014 01:28 PM, David Roldan Puig wrote:
>
>> Hello Vassilis.
>>
>> Yes I know it, My client is in the server side of GWT (2.6.1)
>> I have a service that is called in a Async way and the code is inside it,
>> just in the server part of the project
>> The error is generated when the thread executes the line: Response
>> response = resource.getDomains();
>>
>> But is it necessary to import resty-gwt jar to the project?
>> Is it necessary to define<inherits name="org.fusesource.restygwt.
>> RestyGWT"/>
>> in my gwt.xml?
>>
>> thanks
>>
>> *David Roldán*
>>
>> *UITU: Ubiquitous Internet Technologies Unit *
>> http://fi2.cat/uitudesc
>>
>> *i2CAT FOUNDATION*
>> Gran Capità 2-4 (Nexus I building)
>> 2nd Floor, office 203; 08034 Barcelona
>> +34 93 553 26 33
>>
>> 2014-10-16 12:05 GMT+02:00 Vassilis Virvilis <[email protected]>:
>>
>> Hi David,
>>>
>>> I am not 100% sure but looks like that you try to use cxf jax-rs client
>>> in
>>> GWT client side. I am afraid this is not possible. GWT is a java to
>>> javascript compiler and only certain - blessed/specially crafted GWT
>>> specific jars are allowed client side.
>>>
>>> I have used Resty-GWT http://resty-gwt.github.io/ as a client for CXF
>>> services with great success.
>>>
>>> Vassilis
>>>
>>>
>>>
>>> On 10/16/2014 12:59 PM, David Roldan Puig wrote:
>>>
>>> Hello,
>>>>
>>>> I would like to create an APIRest Client in a WebProject with Google Web
>>>> toolkit (GWT 2.6.1). I am using CXF in order to use my interfaces to get
>>>> the client.
>>>>
>>>> I use this code to obtain the client in the serviceImplementation class
>>>> inside a package in the server of GWT project:
>>>>
>>>>
>>>>
>>>> DomainsAPI resource = JAXRSClientFactory.create("
>>>> http://localhost:9998/api/v1/";, DomainsAPI.class, providers);
>>>> WebClient.client(resource).header("X-USER",
>>>> userKey).accept(MediaType.APPLICATION_JSON);
>>>> ObjectMapper mapper = new ObjectMapper();
>>>> Response response = resource.getDomains();
>>>> String hp = response.readEntity(String.class);
>>>> Domain[] dd = mapper.readValue(hp, Domain[].class);
>>>> ...
>>>>
>>>>
>>>> POM configuration:
>>>>
>>>> <dependencies>
>>>> <dependency>
>>>> <groupId>com.google.gwt</groupId>
>>>> <artifactId>gwt-servlet</artifactId>
>>>> <version>2.6.1</version>
>>>> <scope>runtime</scope>
>>>> </dependency>
>>>> <dependency>
>>>> <groupId>com.google.gwt</groupId>
>>>> <artifactId>gwt-user</artifactId>
>>>> <version>2.6.1</version>
>>>> <scope>provided</scope>
>>>> </dependency>
>>>> <dependency>
>>>> <groupId>org.apache.cxf</groupId>
>>>> <artifactId>cxf-rt-transports-http</artifactId>
>>>> <version>3.0.1</version>
>>>> </dependency>
>>>> <dependency>
>>>> <groupId>org.apache.cxf</groupId>
>>>> <artifactId>cxf-rt-rs-client</artifactId>
>>>> <version>3.0.1</version>
>>>> </dependency>
>>>> <dependency>
>>>> <groupId>org.codehaus.jackson</groupId>
>>>> <artifactId>jackson-jaxrs</artifactId>
>>>> <version>1.9.13</version>
>>>> </dependency>
>>>> </dependencies>
>>>>
>>>>
>>>> This code is processed but when resource.getDomains() is called, I
>>>> obtain
>>>> the typical error with GWT and CXF:
>>>>
>>>> Advertencia: Interceptor for {
>>>> http://clientAPIRest.shared.us2p.uitu.com/}DomainsAPI has thrown
>>>> exception,
>>>> unwinding now
>>>> org.apache.cxf.interceptor.Fault: No conduit initiator was found for
>>>> the
>>>> namespace http://cxf.apache.org/transports/http.
>>>>
>>>> ....
>>>> Caused by: org.apache.cxf.BusException: No conduit initiator was found
>>>> for
>>>> the namespace http://cxf.apache.org/transports/http.
>>>> at
>>>> org.apache.cxf.bus.managers.ConduitInitiatorManagerImpl.
>>>> getConduitInitiator(ConduitInitiatorManagerImpl.java:110)
>>>> at
>>>> org.apache.cxf.endpoint.AbstractConduitSelector.getSelectedConduit(
>>>> AbstractConduitSelector.java:104)
>>>> ....
>>>>
>>>>
>>>> But, if I try this code in a stand alone maven project with its
>>>> dependencies works properly. The sample code is the same as above and
>>>> the
>>>> dependencies in POM maven are the following:
>>>>
>>>> <dependencies>
>>>>
>>>> <dependency>
>>>>
>>>> <groupId>org.apache.cxf</groupId>
>>>>
>>>> <artifactId>cxf-rt-transports-http</artifactId>
>>>>
>>>> <version>3.0.1</version>
>>>>
>>>> </dependency>
>>>>
>>>> <dependency>
>>>>
>>>> <groupId>org.apache.cxf</groupId>
>>>>
>>>> <artifactId>cxf-rt-rs-client</artifactId>
>>>>
>>>> <version>3.0.1</version>
>>>>
>>>> </dependency>
>>>>
>>>> </dependencies>
>>>>
>>>>
>>>>
>>>> I don't know exactly where is the problem. I saw lots of comments about
>>>> CXF
>>>> dependencies but no one is the solution I amb looking for.
>>>> The project works without GWT so the problem is in the integration
>>>> between
>>>> them, I don't know exactly.
>>>>
>>>> I hope your help.
>>>> Thanks a lot.
>>>>
>>>> Regards
>>>>
>>>> *David Roldán*
>>>>
>>>> *UITU: Ubiquitous Internet Technologies Unit *
>>>> http://fi2.cat/uitudesc
>>>>
>>>> *i2CAT FOUNDATION*
>>>> Gran Capità 2-4 (Nexus I building)
>>>> 2nd Floor, office 203; 08034 Barcelona
>>>> +34 93 553 26 33
>>>>
>>>>
>>>> --
>>>
>>> __________________________________
>>>
>>> Vassilis Virvilis Ph.D.
>>> Head of IT
>>> Biovista Inc.
>>>
>>> US Offices
>>> 2421 Ivy Road
>>> Charlottesville, VA 22903
>>> USA
>>> T: +1.434.971.1141
>>> F: +1.434.971.1144
>>>
>>> European Offices
>>> 34 Rodopoleos Street
>>> Ellinikon, Athens 16777
>>> GREECE
>>> T: +30.210.9629848
>>> F: +30.210.9647606
>>>
>>> www.biovista.com
>>>
>>> Biovista is a privately held biotechnology company that finds novel uses
>>> for existing drugs, and profiles their side effects using their mechanism
>>> of action. Biovista develops its own pipeline of drugs in CNS, oncology,
>>> auto-immune and rare diseases. Biovista is collaborating with
>>> biopharmaceutical companies on indication expansion and de-risking of
>>> their
>>> portfolios and with the FDA on adverse event prediction.
>>>
>>>
>>>
>>>
>>
> --
>
> __________________________________
>
> Vassilis Virvilis Ph.D.
> Head of IT
> Biovista Inc.
>
> US Offices
> 2421 Ivy Road
> Charlottesville, VA 22903
> USA
> T: +1.434.971.1141
> F: +1.434.971.1144
>
> European Offices
> 34 Rodopoleos Street
> Ellinikon, Athens 16777
> GREECE
> T: +30.210.9629848
> F: +30.210.9647606
>
> www.biovista.com
>
> Biovista is a privately held biotechnology company that finds novel uses
> for existing drugs, and profiles their side effects using their mechanism
> of action. Biovista develops its own pipeline of drugs in CNS, oncology,
> auto-immune and rare diseases. Biovista is collaborating with
> biopharmaceutical companies on indication expansion and de-risking of their
> portfolios and with the FDA on adverse event prediction.
>
>
>
